Table 2.
siRNA | Deteriorated number/ total number |
---|---|
Qa-2 siRNA | 3/6 |
Leader peptide siRNA | 1/6 |
Glucose | 0/7 |
The symptoms of BD mice deteriorated following treatment with Qa-2 siRNA. Qa-2 siRNA was intravenously injected into BD mice four times with a three day interval between injections. Deterioration occurred in three of six BD mice.